Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis

This study has been completed.
Information provided by Office of Rare Diseases (ORD)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004744

Sponsors and Collaborators

Investigators